Total Payments
$434,945
2024 Payments
$57,406
Companies
67
Transactions
2,066
Medicare Patients
3,669
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$309,622 (71.2%)
Consulting$76,089 (17.5%)
Food & Beverage$29,473 (6.8%)
Travel$18,909 (4.3%)
Education$851.54 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300,522 | 148 | 69.1% |
| Consulting Fee | $76,089 | 36 | 17.5% |
| Food and Beverage | $29,473 | 1,799 | 6.8% |
| Travel and Lodging | $18,909 | 53 | 4.3% |
| Honoraria | $9,100 | 7 | 2.1% |
| Education | $851.54 | 23 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $112,326 | 194 | $0 (2024) |
| Biogen, Inc. | $102,696 | 219 | $0 (2024) |
| Genentech USA, Inc. | $61,832 | 265 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $32,182 | 95 | $0 (2024) |
| TG Therapeutics, Inc. | $30,674 | 66 | $0 (2024) |
| EMD Serono, Inc. | $27,496 | 149 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $25,465 | 220 | $0 (2024) |
| Horizon Therapeutics plc | $13,897 | 24 | $0 (2023) |
| Amgen Inc. | $7,546 | 35 | $0 (2024) |
| Celgene Corporation | $4,105 | 78 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,406 | 310 | TG Therapeutics, Inc. ($25,802) |
| 2023 | $52,059 | 300 | GENZYME CORPORATION ($11,693) |
| 2022 | $47,927 | 237 | GENZYME CORPORATION ($13,594) |
| 2021 | $58,425 | 131 | Biogen, Inc. ($26,924) |
| 2020 | $38,803 | 93 | Biogen, Inc. ($14,466) |
| 2019 | $118,430 | 412 | GENZYME CORPORATION ($35,274) |
| 2018 | $34,113 | 292 | GENZYME CORPORATION ($19,577) |
| 2017 | $27,781 | 291 | GENZYME CORPORATION ($12,806) |
All Payment Transactions
2,066 individual payment records from CMS Open Payments — Page 1 of 83
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/26/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| 12/18/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Musculoskeletal | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Neurology | ||||||
| 12/16/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: Immune | ||||||
| 12/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Rare Disease | ||||||
| 12/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.13 | General |
| 12/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.37 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Neurology | ||||||
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.01 | General |
| 12/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.06 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/27/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.31 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 989 | 45,529 | $3.0M | $829,832 |
| 2022 | 15 | 905 | 29,709 | $1.7M | $521,666 |
| 2021 | 15 | 889 | 34,894 | $1.5M | $454,632 |
| 2020 | 17 | 886 | 33,731 | $1.4M | $437,961 |
Total Patients
3,669
Total Services
143,863
Medicare Billing
$2.2M
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2323 | Injection, natalizumab, 1 mg | Office | 2023 | 22 | 17,100 | $598,500 | $317,365 | 53.0% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2023 | 18 | 12,900 | $1.4M | $248,805 | 17.5% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 16 | 4,500 | $405,000 | $172,853 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 167 | 167 | $63,460 | $18,135 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 206 | $45,320 | $16,423 | 36.2% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 95 | 99 | $221,265 | $14,565 | 6.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 86 | 107 | $32,100 | $13,139 | 40.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 53 | 92 | $46,920 | $8,235 | 17.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 44 | 105 | $23,940 | $4,804 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 79 | $11,850 | $4,534 | 38.3% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 30 | 30 | $59,400 | $2,617 | 4.4% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 93 | 9,610 | $14,415 | $2,444 | 17.0% |
| 72142 | Mri scan of upper spinal canal with contrast | Office | 2023 | 27 | 27 | $47,142 | $1,974 | 4.2% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 32 | 367 | $5,505 | $1,332 | 24.2% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 17 | 62 | $10,292 | $965.36 | 9.4% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 12 | 12 | $18,216 | $816.34 | 4.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 19 | 31 | $5,146 | $462.45 | 9.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 22 | 35 | $3,500 | $362.82 | 10.4% |
| J2323 | Injection, natalizumab, 1 mg | Office | 2022 | 18 | 16,501 | $577,500 | $302,522 | 52.4% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2022 | 11 | 6,301 | $693,000 | $127,435 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 329 | $72,380 | $27,970 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 199 | 199 | $75,620 | $21,823 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 135 | $20,250 | $8,070 | 39.8% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 48 | 50 | $111,750 | $7,629 | 6.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 32 | 77 | $39,270 | $7,616 | 19.4% |
About Dr. John Scagnelli, M.D
Dr. John Scagnelli, M.D is a Neurology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437268265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Scagnelli, M.D has received a total of $434,945 in payments from pharmaceutical and medical device companies, with $57,406 received in 2024. These payments were reported across 2,066 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($300,522).
As a Medicare-enrolled provider, Scagnelli has provided services to 3,669 Medicare beneficiaries, totaling 143,863 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Raleigh, NC
- Active Since 08/29/2006
- Last Updated 04/01/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1437268265
Products in Payments
- AUBAGIO (Drug) $67,422
- OCREVUS (Biological) $38,598
- TYSABRI (Biological) $36,297
- BRIUMVI (Drug) $30,674
- LEMTRADA (Drug) $27,747
- TECFIDERA (Drug) $20,568
- VUMERITY (Drug) $18,979
- Mavenclad (Drug) $13,981
- UPLIZNA (Drug) $13,497
- MAYZENT (Drug) $10,930
- Soliris (Drug) $10,929
- Mavenclad (Biological) $10,508
- Ocrevus (Biological) $7,461
- KESIMPTA (Drug) $6,779
- Enspryng (Biological) $6,502
- UPLIZNA (Biological) $5,827
- GILENYA (Drug) $4,658
- ZEPOSIA (Drug) $4,106
- SOLIRIS (Drug) $3,261
- NITYR (Drug) $3,160
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Raleigh
Dr. Tibor Becske, M.d, M.D
Neurology — Payments: $387,165
Neurology $387,165
Dr. Keith Hull, M.d, M.D
Neurology — Payments: $140,830
Neurology $140,830
Dr. Casey Jeffreys, M.d, M.D
Neurology — Payments: $70,215
Neurology $70,215
John Collins, M.d, M.D
Neurology — Payments: $25,595
Neurology $25,595
Dr. Kenneth Carnes, M.d, M.D
Neurology — Payments: $23,277
Neurology $23,277
Dr. William Ferrell, M.d, M.D
Neurology — Payments: $23,271
Neurology $23,271